OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
31
Results
Show all
Save search
Copy query
Show results for
Unknown
(31)
Publication Date
Release Date
2021
(8)
2022
(7)
2023
(5)
2024
(4)
2025
(2)
2020
(2)
2019
(1)
2018
(1)
2013
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV patients with cirrhosis.
Not available
S-EPMC6851829
|
biostudies-literature
Cite
CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative.
Not available
S-EPMC9305285
|
biostudies-literature
Cite
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
Not available
S-EPMC10208981
|
biostudies-literature
Cite
Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study.
Not available
S-EPMC7095489
|
biostudies-literature
Cite
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study.
Not available
S-EPMC7906623
|
biostudies-literature
Cite
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain.
Not available
S-EPMC7399713
|
biostudies-literature
Cite
An interconnected data infrastructure to support large-scale rare disease research.
Not available
S-EPMC11413801
|
biostudies-literature
Cite
Clinical, genetic, epidemiologic, evolutionary, and functional delineation of
TSPEAR
-related autosomal recessive ectodermal dysplasia 14.
Not available
S-EPMC10064225
|
biostudies-literature
Cite
Comprehensive reanalysis for CNVs in ES data from unsolved rare disease cases results in new diagnoses.
Not available
S-EPMC11513043
|
biostudies-literature
Cite
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Not available
S-EPMC3596060
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets